{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T22:35:01Z","timestamp":1791412501962,"version":"4.3.3"},"reference-count":43,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,5,5]],"date-time":"2022-05-05T00:00:00Z","timestamp":1651708800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100007054","name":"Meso Scale Diagnostics","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100002491","name":"Bristol-Myers Squibb","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100002491","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008349","name":"Boehringer Ingelheim","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008349","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004337","name":"Roche","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004337","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008373","name":"Takeda Pharmaceutical Company","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008373","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100013220","name":"Ultragenyx Pharmaceutical","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100013220","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100001003","name":"Boehringer Ingelheim","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100001003","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100005564","name":"Gilead Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100005564","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cghjournal.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Gastroenterology and Hepatology"],"published-print":{"date-parts":[[2023,4]]},"DOI":"10.1016\/j.cgh.2022.04.024","type":"journal-article","created":{"date-parts":[[2022,5,6]],"date-time":"2022-05-06T20:50:33Z","timestamp":1651870233000},"page":"978-987.e2","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":37,"title":["Outcome of Budd-Chiari Syndrome Patients Treated With Direct Oral Anticoagulants: An Austrian Multicenter Study"],"prefix":"10.1016","volume":"21","author":[{"given":"Georg","family":"Semmler","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander","family":"Lindorfer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benedikt","family":"Sch\u00e4fer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefan","family":"Bartl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephanie","family":"Hametner-Schreil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sophie","family":"Gensluckner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lorenz","family":"Balcar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katharina","family":"Pomej","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katharina","family":"Lampichler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Trauner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elmar","family":"Aigner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"Datz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heinz","family":"Zoller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harald","family":"Hofer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rainer","family":"Sch\u00f6fl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mattias","family":"Mandorfer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4590-3583","authenticated-orcid":false,"given":"Thomas","family":"Reiberger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bernhard","family":"Scheiner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cgh.2022.04.024_bib1","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1016\/j.clinre.2018.10.014","article-title":"Epidemiology of Budd-Chiari syndrome: a systematic review and meta-analysis","volume":"43","author":"Li","year":"2019","journal-title":"Clin Res Hepatol Gastroenterol"},{"key":"10.1016\/j.cgh.2022.04.024_bib2","doi-asserted-by":"crossref","first-page":"167","DOI":"10.7326\/0003-4819-151-3-200908040-00004","article-title":"Etiology, management, and outcome of the Budd-Chiari syndrome","volume":"151","author":"Darwish Murad","year":"2009","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.cgh.2022.04.024_bib3","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.jhep.2015.07.040","article-title":"Vascular diseases of the liver","volume":"64","year":"2016","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.cgh.2022.04.024_bib4","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1007\/s12072-021-10189-4","article-title":"Budd-Chiari syndrome: consensus guidance of the Asian Pacific Association for the study of the liver (APASL)","volume":"15","author":"Shukla","year":"2021","journal-title":"Hepatol Int"},{"key":"10.1016\/j.cgh.2022.04.024_bib5","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1002\/hep.31646","article-title":"Vascular liver disorders, portal vein thrombosis, and procedural bleeding in patients with liver disease: 2020 Practice Guidance by the American Association for the Study of Liver Diseases","volume":"73","author":"Northup","year":"2021","journal-title":"Hepatology"},{"key":"10.1016\/j.cgh.2022.04.024_bib6","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1007\/s00508-018-1351-y","article-title":"Anticoagulation in non-malignant portal vein thrombosis is safe and improves hepatic function","volume":"130","author":"Scheiner","year":"2018","journal-title":"Wien Klin Wochenschr"},{"key":"10.1016\/j.cgh.2022.04.024_bib7","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1111\/liv.13285","article-title":"Antithrombotic treatment with direct-acting oral anticoagulants in patients with splanchnic vein thrombosis and cirrhosis","volume":"37","author":"De Gottardi","year":"2017","journal-title":"Liver Int"},{"key":"10.1016\/j.cgh.2022.04.024_bib8","article-title":"Effectiveness and safety of non-vitamin K antagonist oral anticoagulant and warfarin in cirrhotic patients with nonvalvular atrial fibrillation","volume":"8","author":"Lee","year":"2019","journal-title":"J\u00a0Am Heart Assoc"},{"key":"10.1016\/j.cgh.2022.04.024_bib9","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1056\/NEJMoa1207541","article-title":"Apixaban for extended treatment of venous thromboembolism","volume":"368","author":"Agnelli","year":"2012","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.cgh.2022.04.024_bib10","doi-asserted-by":"crossref","first-page":"2499","DOI":"10.1056\/NEJMoa1007903","article-title":"Oral rivaroxaban for symptomatic venous thromboembolism","volume":"363","author":"Bauersachs","year":"2010","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.cgh.2022.04.024_bib11","doi-asserted-by":"crossref","first-page":"1562","DOI":"10.1111\/jth.14836","article-title":"Anticoagulant therapy for splanchnic vein thrombosis","volume":"18","author":"Di Nisio","year":"2020","journal-title":"J\u00a0Thromb Haemost"},{"key":"10.1016\/j.cgh.2022.04.024_bib12","doi-asserted-by":"crossref","first-page":"1436","DOI":"10.1016\/j.cgh.2020.08.007","article-title":"Rates of bleeding and discontinuation of direct oral anticoagulants in patients with decompensated cirrhosis","volume":"19","author":"Mort","year":"2021","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.cgh.2022.04.024_bib13","doi-asserted-by":"crossref","first-page":"2159","DOI":"10.1111\/liv.14992","article-title":"Safety of direct oral anticoagulants in patients with advanced liver disease","volume":"41","author":"Semmler","year":"2021","journal-title":"Liver Int"},{"key":"10.1016\/j.cgh.2022.04.024_bib14","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1111\/jgh.14843","article-title":"Dabigatran as an oral anticoagulant in patients with Budd-Chiari syndrome post-percutaneous endovascular intervention","volume":"35","author":"Sharma","year":"2020","journal-title":"J\u00a0Gastroenterol Hepatol"},{"key":"10.1016\/j.cgh.2022.04.024_bib15","doi-asserted-by":"crossref","DOI":"10.1259\/bjr.20190847","article-title":"Diagnostic accuracy of Doppler ultrasound, CT and MRI in Budd Chiari syndrome: systematic review and meta-analysis","volume":"93","author":"Gupta","year":"2020","journal-title":"Br J Radiol"},{"key":"10.1016\/j.cgh.2022.04.024_bib16","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1111\/j.1538-7836.2005.01204.x","volume":"3","author":"Schulman","year":"2005","journal-title":"J\u00a0Thromb Haemost"},{"key":"10.1016\/j.cgh.2022.04.024_bib17","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.jhep.2010.06.019","article-title":"Bleeding in patients with Budd-Chiari syndrome","volume":"54","author":"Rautou","year":"2011","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.cgh.2022.04.024_bib18","doi-asserted-by":"crossref","first-page":"1962","DOI":"10.1002\/hep.26306","article-title":"Good long-term outcome of Budd-Chiari syndrome with a step-wise management","volume":"57","author":"Seijo","year":"2013","journal-title":"Hepatology"},{"key":"10.1016\/j.cgh.2022.04.024_bib19","doi-asserted-by":"crossref","first-page":"1561","DOI":"10.1182\/blood.2020005319","article-title":"Anticoagulant activity of edoxaban in patients with cirrhosis","volume":"136","author":"Bos","year":"2020","journal-title":"Blood"},{"key":"10.1016\/j.cgh.2022.04.024_bib20","doi-asserted-by":"crossref","first-page":"1326","DOI":"10.1056\/NEJMoa1814051","article-title":"Full study report of andexanet\u00a0alfa for bleeding associated with factor Xa inhibitors","volume":"380","author":"Connolly","year":"2019","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.cgh.2022.04.024_bib21","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1002\/hep.510300125","article-title":"Outcome of Budd-Chiari syndrome: a multivariate analysis of factors related to survival including surgical portosystemic shunting","volume":"30","author":"Zeitoun","year":"1999","journal-title":"Hepatology"},{"key":"10.1016\/j.cgh.2022.04.024_bib22","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1016\/S0168-8278(03)00323-4","article-title":"Clinicopathological forms and prognostic index in Budd-Chiari syndrome","volume":"39","author":"Langlet","year":"2003","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.cgh.2022.04.024_bib23","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1002\/hep.20064","article-title":"Determinants of survival and the effect of portosystemic shunting in patients with Budd-Chiari syndrome","volume":"39","author":"Darwish Murad","year":"2004","journal-title":"Hepatology"},{"key":"10.1016\/j.cgh.2022.04.024_bib24","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1136\/gut.2005.071423","article-title":"Favourable medium term outcome following hepatic vein recanalisation and\/or transjugular intrahepatic portosystemic shunt for Budd Chiari syndrome","volume":"55","author":"Eapen","year":"2006","journal-title":"Gut"},{"key":"10.1016\/j.cgh.2022.04.024_bib25","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1053\/j.gastro.2008.05.051","article-title":"TIPS for Budd-Chiari syndrome: long-term results and prognostics factors in 124 patients","volume":"135","author":"Garcia-Pag\u00e1n","year":"2008","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cgh.2022.04.024_bib26","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1148\/radiol.2016152641","article-title":"Long-term outcome and analysis of dysfunction of transjugular intrahepatic portosystemic shunt placement in chronic primary Budd-Chiari Syndrome","volume":"283","author":"Hayek","year":"2017","journal-title":"Radiology"},{"key":"10.1016\/j.cgh.2022.04.024_bib27","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1016\/S2468-1253(19)30177-3","article-title":"Angioplasty with versus without routine stent placement for Budd-Chiari syndrome: a randomised controlled trial","volume":"4","author":"Wang","year":"2019","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"10.1016\/j.cgh.2022.04.024_bib28","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1007\/s11239-020-02052-4","article-title":"Portal vein thrombosis patients harboring JAK2V617F have poor long-term outcomes despite anticoagulation","volume":"50","author":"Naymagon","year":"2020","journal-title":"J\u00a0Thromb Thrombolysis"},{"key":"10.1016\/j.cgh.2022.04.024_bib29","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1016\/j.jceh.2018.10.002","article-title":"Patients with Budd-Chiari syndrome have variable coagulation status on thromboelastography at diagnosis","volume":"9","author":"Jain","year":"2019","journal-title":"J\u00a0Clin Exp Hepatol"},{"key":"10.1016\/j.cgh.2022.04.024_bib30","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1136\/gut.2007.139477","article-title":"Hepatocellular carcinoma in Budd-Chiari syndrome: characteristics and risk factors","volume":"57","author":"Moucari","year":"2008","journal-title":"Gut"},{"key":"10.1016\/j.cgh.2022.04.024_bib31","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1097\/MEG.0b013e32835eb8d4","article-title":"Prevalence and risk factors of hepatocellular carcinoma in Budd-Chiari syndrome: a systematic review","volume":"25","author":"Ren","year":"2013","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"10.1016\/j.cgh.2022.04.024_bib32","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1016\/j.jhep.2019.01.009","article-title":"Low specificity of washout to diagnose hepatocellular carcinoma in nodules showing arterial hyperenhancement in patients with Budd-Chiari syndrome","volume":"70","author":"Van Wettere","year":"2019","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.cgh.2022.04.024_bib33","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/0197-2456(96)00075-X","article-title":"A\u00a0note on quantifying follow-up in studies of failure time","volume":"17","author":"Schemper","year":"1996","journal-title":"Control Clin Trials"},{"key":"10.1016\/j.cgh.2022.04.024_bib34","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1002\/hep.510300125","article-title":"Outcome of Budd-Chiari syndrome: a multivariate analysis of factors related to survival including surgical portosystemic shunting","volume":"30","author":"Zeitoun","year":"1999","journal-title":"Hepatology"},{"key":"10.1016\/j.cgh.2022.04.024_bib35","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1016\/S0168-8278(03)00323-4","article-title":"Clinicopathological forms and prognostic index in Budd-Chiari syndrome","volume":"39","author":"Langlet","year":"2003","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.cgh.2022.04.024_bib36","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1002\/hep.20064","article-title":"Determinants of survival and the effect of portosystemic shunting in patients with Budd-Chiari syndrome","volume":"39","author":"Darwish Murad","year":"2004","journal-title":"Hepatology"},{"key":"10.1016\/j.cgh.2022.04.024_bib37","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1136\/gut.2005.071423","article-title":"Favourable medium term outcome following hepatic vein recanalisation and\/or transjugular intrahepatic portosystemic shunt for Budd Chiari syndrome","volume":"55","author":"Eapen","year":"2006","journal-title":"Gut"},{"key":"10.1016\/j.cgh.2022.04.024_bib38","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1053\/j.gastro.2008.05.051","article-title":"TIPS for Budd-Chiari syndrome: long-term results and prognostics factors in 124 patients","volume":"135","author":"Garcia-Pag\u00e1n","year":"2008","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cgh.2022.04.024_bib39","doi-asserted-by":"crossref","first-page":"167","DOI":"10.7326\/0003-4819-151-3-200908040-00004","article-title":"Etiology, management, and outcome of the Budd-Chiari syndrome","volume":"151","author":"Darwish Murad","year":"2009","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.cgh.2022.04.024_bib40","doi-asserted-by":"crossref","first-page":"1140","DOI":"10.1038\/ajg.2009.63","article-title":"Prognostic indices for Budd-Chiari syndrome: valid for clinical studies but insufficient for individual management","volume":"104","author":"Rautou","year":"2009","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.cgh.2022.04.024_bib41","doi-asserted-by":"crossref","first-page":"1962","DOI":"10.1002\/hep.26306","article-title":"Good long-term outcome of Budd-Chiari syndrome with a step-wise management","volume":"57","author":"Seijo","year":"2013","journal-title":"Hepatology"},{"key":"10.1016\/j.cgh.2022.04.024_bib42","doi-asserted-by":"crossref","first-page":"1164","DOI":"10.1111\/liv.12355","article-title":"Transjugular intrahepatic portosystemic shunt for Budd-Chiari syndrome: techniques, indications and results on 51 Chinese patients from a single centre","volume":"34","author":"Qi","year":"2014","journal-title":"Liver Int"},{"key":"10.1016\/j.cgh.2022.04.024_bib43","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1148\/radiol.2016152641","article-title":"Long-term outcome and analysis of dysfunction of transjugular intrahepatic portosystemic shunt placement in chronic primary Budd-Chiari syndrome","volume":"283","author":"Hayek","year":"2017","journal-title":"Radiology"}],"container-title":["Clinical Gastroenterology and Hepatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1542356522004499?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1542356522004499?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T05:42:01Z","timestamp":1761543721000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1542356522004499"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4]]},"references-count":43,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2023,4]]}},"alternative-id":["S1542356522004499"],"URL":"https:\/\/doi.org\/10.1016\/j.cgh.2022.04.024","relation":{},"ISSN":["1542-3565"],"issn-type":[{"value":"1542-3565","type":"print"}],"subject":[],"published":{"date-parts":[[2023,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Outcome of Budd-Chiari Syndrome Patients Treated With Direct Oral Anticoagulants: An Austrian Multicenter Study","name":"articletitle","label":"Article Title"},{"value":"Clinical Gastroenterology and Hepatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cgh.2022.04.024","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 by the AGA Institute. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}